Orgenesis Inc.

Biotechnology • Healthcare • Germantown, MD, United States • ORGS (PNK)

Orgenesis Inc., a biotech company, focuses on cell and gene therapies in the United States. It operates through two segments, Octomera and Therapies. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed cell based POCare therapies that are processed and produced under closed and automated POCare technology systems across a collaborative POCare model, POCare network consisting of research institutes and hospitals. Its therapies include autologous; cell-based immunotherapies; and therapeutics for metabolic diseases, anti-viral diseases, and tissue regeneration. It also provides hospital services and cell process development services. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is headquartered in Germantown, Maryland.

480 659 6404 20271 Goldenrod Lane, Germantown, MD 20876, United States

Stock Performance (90 Days)

Data through Dec 29, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Ways to Give - The Carter Center

The Carter Center • Nov 12

GitHub Universe: Large IT orgs share AI automation gains - TechTarget

TechTarget • Oct 30

Global seagrass carbon stock variability and emissions from seagrass loss - Nature

Nature • May 6

Taking Stock: Viet Nam Economic Update, March 2025 - World Bank Group

World Bank Group • Mar 27

International migrant stocks - Migration Data Portal

Migration Data Portal • Feb 12

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Orgenesis Inc. had layoffs?

No layoff events have been recorded for Orgenesis Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Orgenesis Inc. have?

Orgenesis Inc. has approximately 146 employees.

What industry is Orgenesis Inc. in?

Orgenesis Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Orgenesis Inc. a publicly traded company?

Yes, Orgenesis Inc. is publicly traded under the ticker symbol ORGS on the PNK. The company has a market capitalization of approximately $0.00 billion.

Where is Orgenesis Inc. headquartered?

Orgenesis Inc. is headquartered in Germantown, MD, United States at 20271 Goldenrod Lane, Germantown, MD 20876, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.